Colon & Rectal Surgery · San Antonio, TX
NPI
1609039049
Since 2008
Specialty
Colon & Rectal Surgery
Code 208C00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
225 E Sonterra Blvd Ste 215
San Antonio, TX, 78258
Phone (210) 314-7872
Groups this clinician bills Medicare through
Medicare paid, 2024
$127K
762 services
Medicare patients, 2024
242
Average age 71
Drug cost, 2024
$2.3M
1,289 prescriptions
Company payments, 2025
$1,933
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mario A Alcantara was code 99214 (office e&m - established), 318 times for 169 patients. In total Mario A Alcantara billed 762 services in 78 codes, and Medicare paid $127K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 318 | 169 | $87.36 | $28K |
| 99204 Office E&M - New | Office | 107 | 107 | $109.09 | $12K |
| 99233 Hospital E&M - Subsequent | Facility | 34 | 17 | $87.34 | $2,970 |
| 99213 Office E&M - Established | Office | 30 | 27 | $65.87 | $1,976 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 26 | 26 | $173.68 | $4,516 |
| 64561 Neurostimulator - Back | Facility | 22 | 18 | $294.44 | $6,478 |
| 43239 Upper GI Endoscopy | Facility | 21 | 21 | $62.06 | $1,303 |
| 99223 Hospital E&M - Initial | Facility | 15 | 15 | $131.42 | $1,971 |
| 64590 Musculoskeletal | Facility | 11 | 11 | $122.17 | $1,344 |
By year: 2022 $86K for 596 services; 2023 $94K for 654 services; 2024 $127K for 762 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mario A Alcantara prescribed most often to Medicare patients was Sod Sulf-Potass Sulf-Mag Sulf (Sodium, Potassium,mag Sulfates), with 205 prescriptions and refills. In total Mario A Alcantara wrote 1,289 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 205 | 205 | 194 | $12K |
| Pantoprazole Sodium Generic | 153 | 250 | 52 | $1,575 |
| Dicyclomine Hcl Generic | 126 | 141 | 65 | $1,869 |
| Tramadol Hcl Generic | 83 | 83 | 51 | $327 |
| Metoclopramide Hcl Generic | 81 | 92 | 28 | $335 |
| Cholestyramine Cholestyramine (With Sugar) | 47 | 54 | 30 | $2,611 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 43 | 43 | 31 | $442 |
| Gattex Teduglutide | 42 | 42 | Under 11 | $2.2M |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 42 | 42 | 26 | $494 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 35 | 36 | 14 | $3,582 |
| Mirtazapine Generic | 31 | 31 | 13 | $326 |
| Metronidazole Generic | 27 | 27 | 21 | $343 |
| Prednisone Generic | 23 | 23 | 12 | $144 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 21 | 21 | 17 | $109 |
| Ondansetron Odt Ondansetron | 18 | 18 | 14 | $159 |
Brand drugs: 177 claims; generic drugs: 1,112 claims; opioid claims: 133.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mario A Alcantara $1,933 ($1,933 in general payments such as food, travel and fees) from 14 companies. The largest payer was Sanara MedTech Inc. with $440.
| Company | Payments | Amount |
|---|---|---|
| Sanara MedTech Inc. SMTI | 8 | $440 |
| Baxter Healthcare BAX | 3 | $259 |
| Abbvie Inc. ABBV | 13 | $250 |
| Ethicon US, LLC JNJ | 8 | $198 |
| TELA Bio, Inc. TELA | 1 | $166 |
| Medtronic, Inc. MDT | 7 | $154 |
| Lexington Medical, Inc. | 1 | $144 |
| Davol Inc. BDX | 6 | $144 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 4 | $69.61 |
| Integra LifeSciences Corporation IART | 1 | $35.91 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.